Physician
Obstetrics & Gynecology
Dr. Jessica N. McAlpine, MD
Doctor Jessica N. McAlpine, MD is an expert in the field of Obstetrics & Gynecology. He went to Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical college. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. Doctor Jessica N. McAlpine, MD is also published. He has 37 publications published. The lastest publication: "Absence of BRCA/FMR1 Correlations in Women with Ovarian Cancers.'
Publications
- Germline BRCA1 and BRCA2 Mutations in Ovarian Cancer: Utility of a Histology-Based Referral Strategy.
- The role of the fallopian tube in ovarian cancer.
- Preoperative bowel preparation in gynecologic oncology: a review of practice patterns and an impetus to change.
- Specimen Quality Evaluation in Canadian Biobanks Participating in the COEUR Repository.
- HER2 overexpression and amplification is present in a subset of ovarian mucinous carcinomas and can be targeted with trastuzumab therapy.
- Survivorship as an element of clinical trials in ovarian cancer.
- Use of mutation profiles to refine the classification of endometrial carcinomas.
- 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
- Frequency of known gene rearrangements in endometrial stromal tumors.
- Identification of novel therapeutic targets in microdissected clear cell ovarian cancers.
- Human epidermal growth factor receptor 2 overexpression and amplification in mucinous tumours of ovary.
- The significance of surgical staging in intermediate-risk endometrial cancer.
- Subtype-specific mutation of PPP2R1A in endometrial and ovarian carcinomas.
- Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detection.
- Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts.
- Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cyt...
- Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.
- Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies.
- Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer.
- Absence of BRCA/FMR1 Correlations in Women with Ovarian Cancers.
- Risk-reducing bilateral salpingo-oophorectomy and sexual health: a qualitative study.
- The incidence and risk factors associated with postoperative delirium in geriatric patients undergoing surgery for suspected gynecologic malignancies.
- Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
- Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian carcinoma.
- Brain metastases in epithelial ovarian and primary peritoneal carcinoma.
- Tumor heterogeneity in ovarian cancer as demonstrated by in vitro chemoresistance assays.
- First-line therapy in ovarian cancer trials.
- Teaching cervical cancer surgery in low- or middle-resource countries.
- Radiation fields in gynecologic oncology: correlation of soft tissue (surgical) to radiologic landmarks.
- The histologic subtype of ovarian tumors affects the detection rate by pelvic washings.
- Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation.
- Surgical chores and approach in the management of endometrial cancer.
- SOGC–GOC–SCC Joint Policy Statement. No. 255, March 2011. Cervical cancer prevention in low-resource settings.
- Extrarenal Wilms'' tumor of the uterine corpus.
- The multifunctional protein glyceraldehyde-3-phosphate dehydrogenase is both regulated and controls colony-stimulating factor-1 messenger RNA stability in ovarian cancer.
- Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience.
Schools
Johns Hopkins University School of Medicine
Stanford University Hospital
Stanford University School Med
Yale University School Med
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Health Insurance Plan of Greater New York (HIP) PPO
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Oxford Liberty
Education
-
Stanford University -
Johns Hopkins University School of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891119442 |
| Last Name Of The Provider | MCALPINE |
| First Name Of The Provider | JESSICA |
| View All |
Similar Doctors
|
Dr. Maria Rhee, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Howard Simon, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ljiljana Plisic, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Susan M. Richman, MD
This Doctor is OpenDoctor Recommended.
|